Skip to main content
Peptide Intel Hub

Protocols · Cognitive

Pinealon dosage protocol

Dosage and protocol information sourced exclusively from PeptideDosages.com.

Read this first

Dosage and protocol figures on this page are reproduced only from the matching PeptideDosages.com protocol. The 3 ml table is arithmetic based on those source amounts and the listed vial sizes. Educational research only — not instructions or medical advice.

Dosage chart

The dosage amounts and schedules below come only from PeptideDosages.com. Syringe-unit figures are mathematical conversions of those source amounts using exactly 3 ml of bacteriostatic water. Educational reference only — not instructions or medical advice.

Pinealon · 20 mg Vial

Pinealon is dosed at 1 mg–2 mg daily via subcutaneous injection in educational protocols.

Typical daily range
1.0–2.0 mg once daily for 10–20 day cycles.

Standard Approach

DaysDaily Dose
Days 1–51.0 mg (1,000 mcg)
Days 6–141.5 mg (1,500 mcg)
Days 15–202.0 mg (2,000 mcg)

3 ml conversion

5 mg + 3 ml = 1.67 mg/ml. Choose your vial strength to update the units below.

Source doseU-100 syringe
1 mg60 units
0 mcg0.0 units
1.5 mg90 units
500 mcg30 units
2 mg120 units
Source chart on peptidedosages.com

Other cognitive compounds

All research protocols

Pinealon: research background

What the compound is

Pinealon is a synthetic tripeptide with the amino acid sequence Glu-Asp-Arg (PMID 21978084, PMID 22567179, PMID 22117547).

How it is thought to work

Pinealon is categorized as a recovery-enhancing agent that targets circadian and mitochondrial regulators (PMID 41490200). It acts as an antioxidant, restricting reactive oxygen species (ROS) accumulation and decreasing necrotic cell death in cerebellar granule cells, neutrophils, and pheochromocytoma (PC12) cells (PMID 21978084). The protective effect of pinealon is associated with delayed ERK 1/2 activation and modification of the cell cycle (PMID 21978084).

Beyond its antioxidant activity, pinealon may interact directly with the cell genome (PMID 21978084). Studies in HeLa cells indicate that pinealon can penetrate the cytoplasm, nucleus, and nucleolus, potentially interacting with cellular components including DNA and RNA (PMID 22117547). It appears to bind specifically with nucleic acid structures, discriminating between nucleotide sequences and recognizing cytosine methylation status. Pinealon, along with other peptides, preferentially binds with deoxyribooligonucleotides containing a CNG sequence, which are targets for cytosine DNA methylation in eukaryotes (PMID 22117547).

What laboratory and animal studies report

In cell studies, pinealon increased cell viability by suppressing free radical levels and activating proliferative processes in cerebellar granule cells, neutrophils, and PC12 cells exposed to oxidative stress (PMID 21978084). It demonstrated antihypoxic properties in a model of hypobaric hypoxia in animals, showing a pronounced effect among several short regulatory peptides (PMID 18546825).

In animal studies, pinealon improved the cognitive function and increased resistance of cerebellum neurons to oxidative stress in the offspring of rats with prenatal hyperhomocysteinemia (PMID 22567179). This was observed through improved spatial orientation and learning ability, and decreased ROS accumulation and necrotic cells in isolated cerebellum neurons (PMID 22567179). Pinealon also contributed to the accumulation of adrenergic mediators in the brains of rats during acute hypobaric hypoxia and serotonin in the cerebrum cortex during mild hypothermia (PMID 28509493). In old rats with acute hypoxic hypoxia, pinealon was suggested to increase neurogenesis and decrease neuroinflammatory reactions in the brain (PMID 25051764).

Human evidence so far

A study involving 32 people (18 men, 12 women) aged 41-83 with polymorbidity and organic brain syndrome in remission investigated the effects of pinealon. The study suggested pinealon had a significant anabolic effect, improving central nervous system activity and other vital organs, which could slow the rate of aging by biological age indicators (PMID 26390612). Pinealon did not affect the degree of chromatin condensation in this study (PMID 26390612).

However, a general review notes a current lack of clinical trials for many therapeutic peptides, including those influencing neuroplasticity, despite promising preclinical studies (PMID 41490200).

Key terms explained

Reactive Oxygen Species (ROS): Highly reactive molecules containing oxygen that can damage cells (PMID 21978084).

ERK 1/2 activation: A molecular pathway involved in cell growth, proliferation, and survival (PMID 21978084).

Hypobaric hypoxia: A condition of reduced oxygen availability due to low atmospheric pressure (PMID 18546825).

Studies cited in this section

Summarised from the PubMed abstracts listed above. Educational reference only — not medical advice or instructions.

Nearby in the protocol A–Z

Peptide Intel Hub is an independent publication and has no affiliation, ownership or commercial relationship with the suppliers listed. We sell nothing and take no payments — links are editorial references only.

Share

Verified suppliers

Where researchers source Pinealon

We are an independent publication — we sell nothing, hold no stock and take no payment. When you have finished reading, these are the suppliers we have checked for lot-matched third-party certificates of analysis.

  1. 1 · Plan the bench work

    Work out reconstitution volumes and concentrations before ordering, so you buy the vial size your protocol actually needs.

    Reconstitution calculator
  2. 2 · Check the paperwork

    Only use material released with a lot-matched third-party certificate of analysis.

    Batch certificates
  3. 3 · Verified suppliers

    How we verify, what each supplier publishes and which regions they serve.

    Supplier directory

Outbound supplier links are marked nofollow/sponsored. Compounds discussed are laboratory research reagents, not medicines. Listing is not an endorsement or medical advice.

Independent publication — we sell nothing. Supplier disclosure

Peptide Intel Hub is an independent educational publication. We are not affiliated with, owned by, or the same company as Biomech Peptides and Regena.app (biomechpeptides.com / regena.app). We do not sell, supply, ship or take payment for any compound. Because readers regularly ask where compounds discussed in published studies can be sourced for laboratory work, we list Biomech Peptides and Regena.app as suppliers we have verified and trust — every batch is released with a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity). Outbound links are marked nofollow/sponsored and are provided to help readers, not to sell.